Browsing Tag
Foundayo
2 posts
Walmart (NYSE: WMT) expands GLP-1 support as retail healthcare competition moves beyond the prescription counter
Walmart is expanding GLP-1 support with virtual care, nutrition, and pharmacy access. Read why this could deepen its healthcare moat.
FDA approves Lilly’s Foundayo as second oral GLP-1 weight loss pill, challenging Novo Nordisk’s head start
FDA approves Eli Lilly's Foundayo (orforglipron), the second oral GLP-1 obesity pill with no food restrictions. What this means for LLY investors and patients. Read more.